BBLG Bone Biologics Corp
Nasdaq · SEC CIK 1419554 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 34 since 2021-10-19, latest 2026-01-21
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| No open-market trades in the last year. | |||
Transactions 8
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-14 | 2023-09-13 | BBLG | Walsh Deina H | CFO | P - Purchase | $0.64 | +8,000 | 15.0K | +114% | +$5,120 | |
| 2023-09-12 | 2023-09-11 | BBLG | Frelick Jeff | CEO | P - Purchase | $0.69 | +9,500 | 17.2K | +123% | +$6,555 | |
| M | 2023-09-07 | 2023-09-06 | BBLG | Walsh Deina H | CFO | P - Purchase | $0.7096 | +7,000 | 300 | New | +$4,967 |
| 2023-09-05 | 2023-08-31 | BBLG | Frelick Jeff | CEO | P - Purchase | $0.66 | +7,600 | 7,704 | +7,308% | +$5,016 | |
| DI | 2023-03-29 | 2023-03-13 | BBLG | Knight Insurance Company, Ltd | 10% | J - Other | $0.00 | -500.1K | 0 | -100% | $0 |
| DMI | 2021-10-19 | 2021-10-15 | BBLG | HANKEY CAPITAL, LLC | 10% | C - Cnv Deriv | $0.9694 | -3.43M | 7.55M | -31% | -$3.33M |
| DI | 2021-10-19 | 2021-10-15 | BBLG | HANKEY CAPITAL, LLC | 10% | I - Discretionary | $5.24 | +476.2K | 8.03M | +6% | +$2.50M |
| DI | 2021-10-19 | 2021-10-15 | BBLG | HANKEY CAPITAL, LLC | 10% | G - Gift | $0.00 | -1.00M | 7.03M | -13% | $0 |
Purchase Sale Sale after option exercise All abbreviations